Retour sur lavenir.net
   SYENSQO 78.750 € (+1,81 %)     D'IETEREN GROUP 166.400 € (+1,34 %)     AB INBEV 68.060 € (+0,68 %)     SOLVAY 25.400 € (+1,03 %)     PROXIMUS 6.335 € (+1,52 %)     ARGENX SE 870.400 € (-0,11 %)     UCB 210.600 € (+1,20 %)     KBC 133.100 € (+1,53 %)     MELEXIS 67.950 € (+2,33 %)     TUBIZE-FIN 178.900 € (+1,02 %)     AGEAS 76.600 € (+0,99 %)     AGFA-GEVAERT 0.383 € (-0,78 %)     FAGRON 22.050 € (+0,46 %)     UMICORE 21.740 € (+0,28 %)     VGP 71.700 € (0,00 %)     AEDIFICA 65.200 € (-0,61 %)     BPOST 1.216 € (+1,33 %)     OPTION 4.210 € (-0,24 %)     WDP 20.800 € (+0,68 %)     ECONOCOM GROUP 1.475 € (+0,34 %)     ONTEX GROUP 2.180 € (+2,83 %)     XIOR 25.150 € (-0,20 %)     KINEPOLIS GROUP 50.200 € (+1,01 %)     KBC ANCORA 95.300 € (+1,38 %)     CMB.TECH 17.520 € (-0,68 %)     NYXOAH 1.314 € (+0,31 %)     RETAIL ESTATES 64.600 € (0,00 %)     EKOPAK 3.465 € (-2,39 %)     LOTUS BAKERIES 12 560.000 € (+5,02 %)     SOFINA 249.000 € (+1,06 %)     VIOHALCO 16.000 € (+4,44 %)     TINC 11.020 € (0,00 %)     EVS 27.650 € (+0,55 %)     AZELIS GROUP 12.050 € (+0,33 %)     BARCO 7.485 € (+3,53 %)     ASCENCIO 52.600 € (+0,19 %)     ELIA GROUP 120.300 € (-0,33 %)     IBA 15.240 € (0,00 %)     QRF 10.100 € (-0,49 %)     BQUE NAT. BELGIQUE 359.000 € (-0,28 %)     MONTEA 64.100 € (+0,94 %)     WERELDHAVE BELGIUM 50.000 € (+0,20 %)     CELYAD ONCOLOGY 0.236 € (-1,67 %)     CAMPINE 187.500 € (+0,81 %)     GIMV 47.400 € (+2,38 %)     RECTICEL 12.600 € (+0,16 %)     GBL 74.500 € (+0,88 %)     ACKERMANS V.HAAREN 275.200 € (+1,40 %)     BEKAERT 37.950 € (+1,34 %)     COLRUYT 38.620 € (+0,47 %)     SHURGARD 23.750 € (+0,42 %)     CENERGY 23.040 € (+4,63 %)     CARE PROPERTY INV. 12.460 € (+0,48 %)     ONWARD MEDICAL 2.955 € (+2,07 %)     HYLORIS 4.100 € (-2,38 %)     BIOTALYS 2.000 € (+1,01 %)     HOME INVEST BE. 17.900 € (+0,34 %)     SIPEF 109.400 € (+0,55 %)     OXURION 0.002 € (+9,09 %)     DECEUNINCK 2.480 € (0,00 %)  
   HAVAS 18.000 € (-0,55 %)     FDJ UNITED 21.870 € (-0,18 %)     74SOFTWARE 38.000 € (+0,80 %)     STIF 46.160 € (-1,20 %)     METAVISIO 0.001 € (-33,33 %)     AYVENS 9.955 € (-4,92 %)     IPSEN 144.300 € (-7,44 %)     EBUSCO HOLDING 0.192 € (+0,63 %)     STMICROELECTRONICS 45.015 € (+3,59 %)     LVMH 407.900 € (+1,27 %)     AIR LIQUIDE 164.700 € (+0,94 %)     AHOLD DEL 31.780 € (+0,57 %)     ENGIE 23.490 € (-2,25 %)     UNILEVER 53.950 € (-0,15 %)     ADYEN 882.400 € (+0,38 %)     L'OREAL 381.700 € (+1,50 %)     ASML HOLDING 1 494.000 € (+3,32 %)     HEINEKEN 70.780 € (+0,06 %)     SHELL PLC 41.215 € (-0,24 %)     VERALLIA 18.420 € (-2,33 %)     CAPITAL B 6.088 € (+6,99 %)     PERNOD RICARD 59.420 € (-0,03 %)     ATOS GROUP 23.900 € (+0,17 %)     DANONE 60.360 € (-0,30 %)     COFACE 16.980 € (-2,92 %)     ASM INTERNATIONAL 839.000 € (+3,10 %)     ARCELORMITTAL SA 63.260 € (+0,22 %)     SWORD GROUP 29.350 € (+1,03 %)     HERMES INTL 1 328.500 € (-0,23 %)     SANOFI 74.100 € (+0,07 %)     SOITEC 152.000 € (+7,80 %)     VINCI 111.950 € (+1,04 %)     EUROFINS SCIENT. 77.540 € (+1,44 %)     BE SEMICONDUCTOR 190.500 € (+2,06 %)     SPIE 43.660 € (-0,14 %)     THALES 235.300 € (-1,22 %)     AVANTIUM 4.985 € (+0,71 %)     AALBERTS NV 41.340 € (+1,67 %)     SOCIETE GENERALE 74.660 € (+2,85 %)     CBI 0.155 € (+15,16 %)     GENFIT 10.900 € (-5,71 %)     RENAULT 27.380 € (-0,11 %)     VIRIDIEN 92.350 € (-0,05 %)     AXA 44.710 € (-0,04 %)     AIRBUS 194.800 € (+0,73 %)     OVH 18.450 € (+9,24 %)     UNIFY GROUP 1.580 € (-0,50 %)     THEON INTERNAT 31.360 € (-1,13 %)     ALSTOM 14.960 € (-2,09 %)     KENDRION 20.450 € (-0,24 %)     MAGNUM 16.634 € (+1,02 %)     ESSILORLUXOTTICA 141.050 € (+1,47 %)     SAFRAN 329.500 € (+2,01 %)     KPN KON 4.071 € (+1,80 %)     IPSOS 34.180 € (-1,16 %)     EXOSENS 60.150 € (-0,82 %)     MICHELIN 33.380 € (+0,91 %)     VALEO 14.790 € (-0,74 %)     WOLTERS KLUWER 67.880 € (-0,41 %)     SAINT GOBAIN 70.000 € (+1,27 %)  
News Réglementées
14/09/2026 08:05

Intuitive announces expanded indication for da Vinci SP in Europe

EQS-News: Intuitive / Key word(s): Miscellaneous/Miscellaneous
Intuitive announces expanded indication for da Vinci SP in Europe

14.09.2026 / 08:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


CE mark for transvaginal gynecologic procedures expands SP's applications

AUBONNE, Switzerland, Sept. 14, 2026 /PRNewswire/ -- Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced CE mark approval for the indication of transvaginal gynecologic procedures for the da Vinci SP (Single Port) surgical system – marking a world's-first indication for the SP system.

Da Vinci SP

This approval expands da Vinci SP's CE-marked applications in Europe, which currently include endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, transanal colorectal, and breast surgical procedures.

"Building on the strong adoption of da Vinci SP in women's health, this approval is a meaningful step forward, not just as a regulatory milestone, but because it expands access to less invasive options for women across Europe and opens the door to potentially better recovery experiences and outcomes," said Dirk Barten, Intuitive commercial president for Europe.

The da Vinci SP system enables surgeons to perform procedures through a single incision or natural orifice, offering enhanced visualization and precision in narrow or deep anatomical spaces. Through a single-entry point, surgeons can control up to three multi-jointed instruments and a fully articulating 3DHD endoscope, enabling access to complex anatomy with minimal disruption to surrounding tissue.

"Transvaginal procedures expand the natural orifice surgery portfolio of the da Vinci SP System, which to this day includes successful transoral and transanal procedures," said Tilman Schlick, vice president, medical affairs & medical officer at Intuitive in Europe. "These less invasive, scarless surgery approaches have the potential to shorten recovery times and enhance patients' experience as they return to their daily lives. As we continue to innovate across our platforms, we remain focused on helping more patients access the benefits of minimally invasive care."

A growing body of evidence, including more than 1,000 peer-reviewed publications, supports the safety, efficacy, and patient outcomes associated with the da Vinci SP system. Da Vinci SP is also approved for use in the US, Japan, and Korea for a range of procedures spanning multiple surgical disciplines.

Images
Images accompanying this announcement are available here.

About Intuitive
Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, with European headquarters in Aubonne, Switzerland, is a global leader in minimally invasive care and the pioneer of robotic-assisted surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.

About da Vinci Surgical Systems
There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.

For more information, please visit the company's website at www.intuitive.com/en-gb

This material may contain estimates and forecasts from which actual results may differ. Some products, features or technologies may not be available in all countries. Please contact your local Intuitive representative for product availability in your region. Refer to the product specific User Manual for indications, contraindications, warnings and other product information.

© 2026 Intuitive Surgical Operations, Inc. All rights reserved. Product and brand names/logos, including Intuitive, da Vinci, and Ion, are trademarks or registered trademarks of Intuitive Surgical or their respective owner. See intuitive.com/trademarks.

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/intuitive-announces-expanded-indication-for-da-vinci-sp-in-europe-302877010.html

rt.gif?NewsItemId=EN45140&Transmission_Id=202609140200PR_NEWS_EURO_ND__EN45140&DateId=20260914


14.09.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2398358  14.09.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière